Obeticholic acid

Obeticholic acid (also known as OCA) is a bile acid analogue used to treat primary biliary cholangitis (PBC). It works by reducing the levels of bile acids in the liver, which helps to reduce inflammation, improve liver function, and decrease the risk of further damage to the liver. It is generally prescribed for use in combination with ursodeoxycholic acid (UDCA). Common side effects include itching, abdominal pain, and nausea.

Obeticholic acid, also sold under the brand name Ocaliva, is a medication primarily used to address specific liver conditions. Here's a breakdown of its key aspects:

Purpose:

• Primary use: It's approved by the US Food and Drug Administration (FDA) to treat primary biliary cholangitis (PBC) in adults. PBC is a liver disease that damages bile ducts, hindering bile flow and potentially leading to liver damage.
• Mechanism: Obeticholic acid functions as a farnesoid X receptor (FXR) agonist. FXR plays a regulatory role in bile acid and cholesterol metabolism within the liver. By activating FXR, Obeticholic acid:
  • Reduces bile production: This lessens the burden on the damaged bile ducts.
  • Increases bile flow: This helps remove bile acids from the liver, potentially reducing liver injury.

Important Points:

• Not a first-line treatment: Obeticholic acid is usually prescribed when the standard medication, ursodeoxycholic acid (UDCA), is ineffective or not tolerated by the patient.
• Potential side effects: Like any medication, Obeticholic acid can cause side effects, including fatigue, itching, diarrhea, and abdominal pain. In rare instances, it may lead to serious liver damage.
• Prescription requirement: Obeticholic acid is a prescription medication and should only be taken under the strict supervision of a qualified healthcare provider.